AZNCF News and Press, AstraZeneca Plc From 08/27/20

Prospects for treating early stage COVID-19 remain uncertain, with a host of monoclonal antibody products and Starpharma’s (OTCQX: SPHRY ) nasal SPL7013 antiviral spray vying for a role for prevention of infection and early treatment. Here I update on the latest developments with remdes...

When COVID-19 reared its head, of course vaccine-maker Inovio Pharmaceuticals ( INO ) threw its hat into the ring, like it does with each epidemic or pandemic. Is this time going to be different to the last? Or is INO stock set to continue fading. Data by YCharts Figure 1: Year-to-date ...

Teva receives tentative FDA nod for generic idiopathic pulmonary fibrosis treatment Teva Pharmaceutical Industries ( TEVA ) received tentative approval from the FDA for generic pirfenidone. The drug candidate is aimed towards treating idiopathic pulmonary fibrosis. The tentative approval i...

Written by Robert Kovacs Introduction Back in May, I wrote an article in which I suggested that “ with or without a Covid-19 vaccine ”, Pfizer ( PFE ) was a buy. Since then the stock has dropped 15% and climbed back to the price it was a quarter ago. Pfizer is currently t...

Without naming China, Singapore researchers ( Le Bert et al. 2020 ) suggest that T cell cross-reactivity to COVID-19 viral epitopes found in all 23 persons tested 17 years after recovering from the 2003 SARS may "explain some of the differences in infection rates or pathology observed duri...

Quick Take CureVac ( CVAC ) intends to raise $200 million from the sale of its common stock in an IPO, plus another $118 million from a concurrent private placement, according to an amended registration statement . The company is advancing a number of drug development and gene therapy pro...

Introduction After I first published the article " The Coming Stock Market Crash - Smart Money Is Already Ringing The Death Bell " exclusively on my TEV blog and then here , it became my most read article ever on Seeking Alpha. In the article, I pointed out how massively the net assets in...

Background When both large cap biotech ( IBB ) and the smaller names ( XBI ) began to get a bit frothy by late 2014 and most of 2015, I began comparing the sector to tech ( QQQ ) in the 1998 period: not quite a bubble, but close. As it happened, biotech never went to the extremes of the tech...

The art of medicine consists of amusing the patient while nature cures the disease. ― Voltaire At first glance, Tekla World Healthcare Fund ( THW ) looks like a solid dividend bet because it has been paying dividends consistently since inception and it sports an attractive dividend ...

Quick Take CureVac B.V. ( CVAC ) has filed to raise $100 million in an IPO of its common shares, according to an F-1 registration statement . The firm is developing a wide range of treatments, vaccines and therapies based on messenger RNA technologies. CVAC has developed extensive colla...